November 2022 FDA Recall Drug by Accord Healthcare, Inc.
D-0131-2023 - Labeling mixup
This Class I drug recall was voluntarily initiated by Accord Healthcare, Inc. on November 29, 2022 for the product Drug. The FDA reported the reason for recall as labeling mixup. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0131-2023
Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial
11-29-2022
01-25-2023
Unknown
Recall Profile & Regulatory Data
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Accord Healthcare, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide within the United States
02-22-2024
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, India. NDC 16729-0434-05
Batch or Lot Expiration Information
Lot# Lot: R2200232 Exp. 01/2025